02-03 July 2019
Boston, MA, USA


2018 Brochure Download

Developed with experts at Lundbeck, Roche, GSK and 20 other leading organisations, the inaugural Neuropsychiatric Drug Development summit will enable you to solve the challenges in bringing next generation neuropsychiatric therapeutics to market.

Join your peers at NDD to be part of the cross-industry discussion on latest developments, insights and science to elevate clinically effective neuropsychiatric therapeutic pipelines